By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company PharmaCielo Ltd.

PharmaCielo Ltd. (PCLOF)

OTC Market Data in USD, Fundamentals in CAD
$0.03
+$0.01
+48.15%
Last Update: 2 Sept 2025, 18:49
$6.01M
Market Cap
-1.16
P/E Ratio (TTM)
Forward Dividend Yield
$0.02 - $0.15
52 Week Range

PCLOF Stock Price Chart

Explore PharmaCielo Ltd. interactive price chart. Choose custom timeframes to analyze PCLOF price movements and trends.

PCLOF Company Profile

Discover essential business fundamentals and corporate details for PharmaCielo Ltd. (PCLOF) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

25 Jan 2019

Employees

268.00

CEO

Marc Lustig

Description

PharmaCielo Ltd., together with its subsidiary, cultivates, processes, produces, and supplies medicinal-grade cannabis extracts, tetrahydrocannabinol, and related products. The company also offers telemedicine software. It serves health and wellness product manufacturers, pharmacies, medical clinics, and cosmetic companies in Canada and Colombia. The company has a strategic alliance with AssuredTrans Inc. PharmaCielo Ltd. is headquartered in Toronto, Canada.

PCLOF Financial Timeline

Browse a chronological timeline of PharmaCielo Ltd. corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 1 Dec 2025

Earnings released on 3 Sept 2025

Earnings released on 28 Aug 2025

Earnings released on 18 Jun 2025

Earnings released on 28 Feb 2025

EPS came in at -$0.01 , while revenue for the quarter reached $783.13K .

Earnings released on 27 Nov 2024

EPS came in at -$0.01 , while revenue for the quarter reached $979.22K .

Earnings released on 16 Aug 2024

EPS came in at -$0.01 falling short of the estimated $0.03 by -136.78%, while revenue for the quarter reached $573.20K , missing expectations by -95.72%.

Earnings released on 26 Jun 2024

EPS came in at -$0.01 falling short of the estimated $0.03 by -134.89%, while revenue for the quarter reached $176.93K , missing expectations by -98.68%.

Earnings released on 20 Feb 2024

EPS came in at -$0.03 , while revenue for the quarter reached $183.73K .

Earnings released on 29 Nov 2023

EPS came in at -$0.01 falling short of the estimated $0.02 by -156.97%, while revenue for the quarter reached $259.64K , missing expectations by -97.75%.

Earnings released on 29 Aug 2023

EPS came in at -$0.02 falling short of the estimated $0.02 by -176.23%, while revenue for the quarter reached $120.43K , missing expectations by -98.84%.

Earnings released on 29 May 2023

EPS came in at -$0.02 , while revenue for the quarter reached $581.24K , missing expectations by -90.58%.

Earnings released on 28 Apr 2023

EPS came in at -$0.01 , while revenue for the quarter reached $1.13M .

Earnings released on 31 Oct 2022

EPS came in at -$0.03 falling short of the estimated -$0.01 by -245.78%, while revenue for the quarter reached $347.09K , missing expectations by -92.98%.

Earnings released on 30 Aug 2022

EPS came in at -$0.02 falling short of the estimated -$0.02 by -16.68%, while revenue for the quarter reached $1.64M , missing expectations by -56.91%.

Earnings released on 30 May 2022

EPS came in at -$0.02 surpassing the estimated -$0.02 by +2.50%, while revenue for the quarter reached $960.77K , missing expectations by -63.61%.

Earnings released on 29 Apr 2022

EPS came in at -$0.02 surpassing the estimated -$0.02 by +8.64%, while revenue for the quarter reached $265.55K , missing expectations by -71.51%.

Earnings released on 26 Nov 2021

EPS came in at -$0.06 falling short of the estimated -$0.03 by -100.00%, while revenue for the quarter reached $382.70K .

Earnings released on 20 Aug 2021

EPS came in at -$0.04 falling short of the estimated -$0.03 by -33.33%, while revenue for the quarter reached $359.78K .

Earnings released on 31 May 2021

EPS came in at -$0.05 falling short of the estimated $0.05 by -200.00%, while revenue for the quarter reached $537.25K .

Earnings released on 3 May 2021

EPS came in at -$0.16 falling short of the estimated -$0.02 by -900.00%, while revenue for the quarter reached $690.17K .

Earnings released on 30 Nov 2020

EPS came in at -$0.05 falling short of the estimated -$0.01 by -600.28%, while revenue for the quarter reached $19.46K .

PCLOF Stock Performance

Access detailed PCLOF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run